ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08945
-0,01%
Bitcoin
66.907,74
-0,25%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Statera BioPharma Inc (STAB)

  7. Statera BioPharma Inc (STAB) News

STAB

Statera BioPharma (STAB)

Statera BioPharma Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:STAB
DatumZeitQuelleÜberschriftSymbolFirma
15/03/202313h00GlobeNewswire Inc.Statera Biopharma Signs Letter of Intent for Merger with Worksite LabsNASDAQ:STABStatera BioPharma Inc
03/03/202316h47Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:STABStatera BioPharma Inc
27/02/202312h08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:STABStatera BioPharma Inc
15/02/202315h10Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:STABStatera BioPharma Inc
01/02/202322h35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STABStatera BioPharma Inc
01/02/202322h10Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:STABStatera BioPharma Inc
18/11/202214h04Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:STABStatera BioPharma Inc
15/11/202212h34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STABStatera BioPharma Inc
14/11/202223h53Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:STABStatera BioPharma Inc
27/10/202223h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STABStatera BioPharma Inc
21/10/202215h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:STABStatera BioPharma Inc
17/10/202223h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STABStatera BioPharma Inc
06/10/202212h01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:STABStatera BioPharma Inc
23/09/202212h02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:STABStatera BioPharma Inc
09/09/202212h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STABStatera BioPharma Inc
26/08/202213h49GlobeNewswire Inc.Nasdaq Resumes Trading in Statera Biopharma, Inc.NASDAQ:STABStatera BioPharma Inc
25/08/202217h48GlobeNewswire Inc.Nasdaq Halts Statera Biopharma, Inc.NASDAQ:STABStatera BioPharma Inc
03/08/202221h00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STABStatera BioPharma Inc
14/06/202213h30GlobeNewswire Inc.Statera Biopharma Announces BF Borgers CPA PC as Independent Registered Public Accounting FirmNASDAQ:STABStatera BioPharma Inc
06/06/202222h53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STABStatera BioPharma Inc
27/05/202223h55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STABStatera BioPharma Inc
23/05/202222h05GlobeNewswire Inc.Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-Q FilingNASDAQ:STABStatera BioPharma Inc
13/05/202213h30GlobeNewswire Inc.Statera Biopharma and Lay Sciences Inc. Announce Intent to Enter Strategic Partnership to License the Manufacturing Rights to Certain Lay Sciences IgY ProductsNASDAQ:STABStatera BioPharma Inc
27/04/202222h10GlobeNewswire Inc.Statera Biopharma and Immune Therapeutics Inc. Announce Strategic Agreement for Rights to Low Dose NaltrexoneNASDAQ:STABStatera BioPharma Inc
22/04/202223h26GlobeNewswire Inc.Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-K FilingNASDAQ:STABStatera BioPharma Inc
18/04/202222h56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STABStatera BioPharma Inc
15/04/202223h15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STABStatera BioPharma Inc
13/04/202222h05GlobeNewswire Inc.Statera Biopharma and Coeptis Therapeutics Announce Strategic Agreement for Rights to EntolimodNASDAQ:STABStatera BioPharma Inc
13/04/202215h23Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:STABStatera BioPharma Inc
13/04/202213h00PR Newswire (US)Coeptis Therapeutics Announces Intent to Acquire TLR5 Agonist Platform, Including Clinical-Stage Asset Entolimod, from Statera BiopharmaNASDAQ:STABStatera BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:STAB

Kürzlich von Ihnen besucht

BIT
P1S278
NLBNPIT1S278 20241220 140
BIT
P20EB1
NLBNPIT20EB1 20351221 0....
NASDAQ
PEGRU
Project Energy Reimagine...
BIT
P1VFU4
NLBNPIT1VFU4 20351219 15...
BIT
P1WUE5
NLBNPIT1WUE5 20240920 35
LSE
AMDS
Ls -1x Amd
BIT
XRES
Invesco Real Estate S&P ...
BIT
P1RY37
NLBNPIT1RY37 20240621 6.5
BIT
P1VF75
NLBNPIT1VF75 20240621 11
BIT
P1Z2K7
NLBNPIT1Z2K7 20351221 29...
BIT
P21XD5
NLBNPIT21XD5 20240614 90
AQSE
BATG.GB
L&G Battery ValueChain U...
BIT
P1X5Z0
NLBNPIT1X5Z0 20240920 24
BIT
P1ZRY2
NLBNPIT1ZRY2 20351221 29...
BIT
F18273
Vontobel Financial Produ...
BIT
P21YB7
NLBNPIT21YB7 20240621 9.5
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten